Biovance Capital: Investing in Early-Stage Biopharma Companies Across Europe
Biovance Capital is dedicated to investing in disruptive, early-stage biopharma companies across Europe. Their mission is to support the development of innovative therapies that improve patient outcomes. With a focus on sustainability and a strong collaborative network, they aim to bridge the gap between research and real-world medical treatments.